http://www.fpnotebook.com/
Lidocaine
- Mechanism
- Suppresses ventricular arrhythmias
- Decreases automaticity
- Increases Ventricular Fibrillation threshold
- Requires high plasma lidocaine levels (6 ug/ml)
- Suppresses ventricular ectopy
- Local Anesthetic effect
- Post Myocardial Infarction
- Routine prophylactic lidocaine use not recommended
- Terminates reentrant ventricular arrhythmia
- Indications
- Ventricular Fibrillation
- Ventricular Tachycardia (Wide Complex Tachycardia)
- Use Lidocaine only if unknown etiology
- Not indicated for drug induced arrhythmia
- Not indicated for metabolic induced arrhythmia
- Post-Resuscitation for ventricular arrhythmia
- Myocarditis
- Structural heart disease
- Contraindications
- Wide-complex ventricular escape rhythm
- Associated with Bradycardia
- Pediatric Dosing
- Dose: 1 mg/kg IV/IO/ET
- Adult Dosing
- Ventricular Fibrillation
- Dose: 1.0-1.5 mg/kg IV push
- May repeat in 3-5 min to max dose 3 mg/kg
- Ventricular Tachycardia (with a pulse)
- First: 1.0-1.5 mg/kg IV push
- Next: 0.5-0.75 mg/kg IV push (max total 3 mg/kg)
- Infusion Dosing (Pediatric and Adult)
- Lidocaine 120 mg in 100 ml D5W
- Precede infusion with 1 mg/kg bolus loading dose
- Then 20-50 ug/kg/min (1-2.5 ml/kg/h) Infusion
- If hepatic blood flow is compromised (e.g. CHF)
- Decrease dose to under 20 ug/kg/min
- Adverse Effects
- Myocardial depression of conduction and contractility
- Concurrent Antiarrhythmic therapy
- Sick Sinus Syndrome
- Left Ventricular Dysfunction
- Circulatory depression
- Neurologic changes
- Drowsiness or disorientation
- Decreased hearing acuity
- Paresthesia and muscle twitching
- Seizures
- Overdosage
- Third degree AV Heart Block
- Altered AV conduction
- Sinus node automaticity depressed
Navigation Tree